Bio Rad Laboratories Inc Revenue Growth Rates (BIO), Current and Historic Growth - CSIMarket
CSIMarket
 


Bio rad Laboratories Inc   (NYSE: BIO)
 

BIO's Revenue Growth by Quarter and Year

Bio Rad Laboratories Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BIO/growth
https://api.csimarket.com/api/v1/companies/BIO/fundamentals
https://api.csimarket.com/api/v1/companies/BIO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BIO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 656.40
2nd Quarter June 651.00
1st Quarter March 591.40
FY 1,898.80

BIOs Annual Revenue
Bio Rad Laboratories Inc 's Revenue in the fiscal year 2025 $ 2,582.90 millions
Bio Rad Laboratories Inc 's Revenue in the fiscal year 2024 $ 2,565.90 millions
Bio Rad Laboratories Inc 's Revenue in the fiscal year 2023 $ 2,670.95 millions
Bio Rad Laboratories Inc 's Revenue in the fiscal year 2022 $ 2,802.25 millions
Bio Rad Laboratories Inc 's Revenue in the fiscal year 2021 $ 2,922.55 millions




BIO Revenue third quarter 2026 Y/Y Growth Comment
Bio rad Laboratories Inc reported Revenue growth of 0.61% year on year in the third quarter 2026, to $ 656.40 millions, this is lower than Bio Rad Laboratories Inc 's recent average Revenue growth of 2.36%.

Looking into third quarter 2026 results within Laboratory Analytical Instruments industry 15 other companies have achieved higher Revenue growth. While Bio Rad Laboratories Inc ' s Revenue increase of 0.61% ranks overall at the positon no. 2790 in the third quarter 2026.




BIO Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.61 %
2nd Quarter June -0.05 %
1st Quarter March 1.09 %
FY   -

Financial Statements
Bio Rad Laboratories Inc 's third quarter 2026 Revenue $ 656.40 millions BIO's Income Statement
Bio Rad Laboratories Inc 's third quarter 2025 Revenue $ 652.40 millions Quarterly BIO's Income Statement


BIO Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.83 %
2nd Quarter June 10.08 %
1st Quarter March -14.81 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #16
Healthcare Sector #397
Overall #2790

Revenue Y/Y Growth Statistics
High Average Low
33.35 % 2.36 % -11.44 %
(Jun 30 2021)   (Jun 30 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #16
Healthcare Sector #397
Overall #2790
Revenue Y/Y Growth Statistics
High Average Low
33.35 % 2.36 % -11.44 %
(Jun 30 2021)   (Jun 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Bio Rad Laboratories Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
22.03 % 1.15 % -20.96 %
(Dec 31 2020)  


BIO's III. Quarter Q/Q Revenue Comment
Bio rad Laboratories Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.83% quarter on quarter, to $ 656.40 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.17% in the III. Quarter a year ago.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Bio Rad Laboratories Inc 's Revenue growth quarter on quarter, overall rank is 826.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #125
Overall #826
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #125
Overall #826
Revenue Q/Q Growth Statistics
High Average Low
22.03 % 1.15 % -20.96 %
(Dec 31 2020)  


BIO's III. Quarter Q/Q Revenue Comment
Bio rad Laboratories Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.83% quarter on quarter, to $ 656.40 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.17% in the III. Quarter a year ago.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Bio Rad Laboratories Inc 's Revenue growth quarter on quarter, overall rank is 826.


Bio Rad Laboratories Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 2,593.00
Y / Y Revenue Growth (TTM) 1.38 %
Year on Year Revenue Growth Overall Ranking # 2494
Seqeuential Revenue Change (TTM) 0.15 %
Seq. Revenue Growth (TTM) Overall Ranking # 2582


Cumulative Revenue growth Comment
Although Bio Rad Laboratories Inc 's Annual Revenue growth year on year were below company's average 1.9% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.38% year on year, from 1.37% in Jun 30 2026.

In the Healthcare sector 360 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2494, from total ranking in previous quarter at 2546.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 361
Overall # 2494

Revenue TTM Y/Y Growth Statistics
High Average Low
25.56 %
1.9 %
-7.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 373
S&P 500 # 2582
Cumulative Revenue growth Comment
Although Bio Rad Laboratories Inc 's Annual Revenue growth year on year were below company's average 1.9% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.38% year on year, from 1.37% in Jun 30 2026.

In the Healthcare sector 360 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2494, from total ranking in previous quarter at 2546.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 361
Overall # 2494

Revenue TTM Y/Y Growth Statistics
High Average Low
25.56 %
1.9 %
-7.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 373
S&P 500 # 2582




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIO's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Puma Biotechnology Inc 1.07%$ 1.067 millions
3m Company1.03%$ 1.028 millions
Bio rad Laboratories Inc 0.61%$ 0.613 millions
Cvrx inc 0.57%$ 0.574 millions


About Bio Rad Laboratories Inc Revenue Growth Rates (BIO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bio Rad Laboratories Inc (CIK 12208).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000012208-26-000058
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bio Rad Laboratories Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.